IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R α and γ chains

被引:20
作者
Chou, YK
Bourdette, DN
Barnes, D
Finn, TP
Murray, S
Unsicker, L
Robey, I
Whitham, RH
Buenafe, AC
Allegretta, M
Offner, H
Vandenbark, AA
机构
[1] Vet Affairs Med Ctr, Serv Neurol, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA
[3] Connet Corp, Palo Alto, CA 94303 USA
[4] Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA
关键词
IL-7; IL-2R; human T cells; survival factor;
D O I
10.1016/S0165-5728(99)00002-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-7 has demonstrated potent enhancing effects on the growth and differentiation of several immature cell types, including thymocytes, and on survival of resting and antigen activated T cells. In this study, we evaluated the effects of IL-7 on post-thymic antigen-specific T cells from human blood. IL-7 was found to enhance proliferation responses and IFN-gamma secretion of myelin or recall Ag-specific Th1 cells through the selective up-regulation of the IL-2R alpha and gamma but not beta chains in both an Ag-dependent and Ag-independent manner, but did not affect monocytes, B cells, or NK cells. These functions of IL-7 enhanced the detection of Th1 but not Th2 cell frequency by > 2.5 fold, and promoted selection of kg-specific Th1 cells by the limiting dilution method. Moreover, IL-7 pretreatment conferred increased resistance of CD4 + T cells to CD8 + cell lysis, These studies demonstrate that IL-7 promotes the growth and survival of circulating Ag-specific human Th1 cells through a mechanism that probably involves the gamma c common receptor for IL-2 family members that includes IL-7. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:101 / 111
页数:11
相关论文
共 44 条
  • [31] CLONING OF THE GAMMA-CHAIN OF THE HUMAN IL-2 RECEPTOR
    TAKESHITA, T
    ASAO, H
    OHTANI, K
    ISHII, N
    KUMAKI, S
    TANAKA, N
    MUNAKATA, H
    NAKAMURA, M
    SUGAMURA, K
    [J]. SCIENCE, 1992, 257 (5068) : 379 - 382
  • [32] TAMURA T, 1995, J IMMUNOL, V155, P4692
  • [33] THE IL-2/IL-2 RECEPTOR SYSTEM - A CURRENT OVERVIEW
    TANIGUCHI, T
    MINAMI, Y
    [J]. CELL, 1993, 73 (01) : 5 - 8
  • [34] TASWELL C, 1981, J IMMUNOL, V126, P1614
  • [35] Ting CC, 1996, CANCER IMMUNOL IMMUN, V43, P283
  • [36] TUSHINSKI RJ, 1991, EXP HEMATOL, V19, P749
  • [37] EPISODIC CHANGES IN T-CELL FREQUENCIES TO MYELIN BASIC-PROTEIN IN PATIENTS WITH MULTIPLE-SCLEROSIS
    VANDENBARK, AA
    BOURDETTE, DN
    WHITHAM, R
    CHOU, YK
    HASHIM, GA
    OFFNER, H
    [J]. NEUROLOGY, 1993, 43 (11) : 2416 - 2417
  • [38] FRACTIONATION OF CENTRAL-NERVOUS-SYSTEM MYELIN PROTEINS BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    VANNOORT, JM
    ELOUAGMIRI, M
    BOON, J
    VANSECHEL, AC
    [J]. JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 653 (02): : 155 - 161
  • [39] The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
    VanParijs, L
    Ibraghimov, A
    Abbas, AK
    [J]. IMMUNITY, 1996, 4 (03) : 321 - 328
  • [40] Interleukin-7 treatment promotes the differentiation pathway of T-cell-receptor-αβ cells selectively to the CD8+ cell lineage
    Varas, A
    Vicente, A
    Jiménez, E
    Alonso, L
    Moreno, J
    Muñoz, JJ
    Zapata, AG
    [J]. IMMUNOLOGY, 1997, 92 (04) : 457 - 464